nitroglycerin has been researched along with Constipation in 7 studies
Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.
Constipation: Infrequent or difficult evacuation of FECES. These symptoms are associated with a variety of causes, including low DIETARY FIBER intake, emotional or nervous disturbances, systemic and structural disorders, drug-induced aggravation, and infections.
Excerpt | Relevance | Reference |
---|---|---|
"Clinical and exercise responses to therapy with the calcium-channel blocking agent verapamil were assessed in 26 patients with stable exertional angina pectoris using a double-blind, placebo-controlled, randomized crossover study design." | 9.05 | Verapamil therapy for stable exertional angina pectoris. ( Klein, MD; Weiner, DA, 1982) |
"The clinical responses to 12 months' treatment with verapamil were evaluated in 63 patients with stable and unstable angina pectoris in whom the effectiveness of verapamil had been established in short-term double-blind placebo-controlled randomized clinical trials." | 9.05 | Long-term effectiveness of verapamil in stable and unstable angina pectoris. One-year follow-up of patients treated in placebo-controlled double-blind randomized clinical trials. ( Frishman, WH; Mehta, J; Packer, M; Parodi, O; Scheidt, S; Subramanian, VB, 1982) |
" The efficacy of verapamil in a dose of 360 mg daily in patients with chronic stable angina pectoris was assessed by quantitative serial treadmill exercise tests and trinitrin consumption." | 5.05 | An objective comparison of verapamil and placebo in chronic stable angina. ( Balasubramanian, V; Raftery, EB, 1982) |
"Clinical and exercise responses to therapy with the calcium-channel blocking agent verapamil were assessed in 26 patients with stable exertional angina pectoris using a double-blind, placebo-controlled, randomized crossover study design." | 5.05 | Verapamil therapy for stable exertional angina pectoris. ( Klein, MD; Weiner, DA, 1982) |
"The clinical responses to 12 months' treatment with verapamil were evaluated in 63 patients with stable and unstable angina pectoris in whom the effectiveness of verapamil had been established in short-term double-blind placebo-controlled randomized clinical trials." | 5.05 | Long-term effectiveness of verapamil in stable and unstable angina pectoris. One-year follow-up of patients treated in placebo-controlled double-blind randomized clinical trials. ( Frishman, WH; Mehta, J; Packer, M; Parodi, O; Scheidt, S; Subramanian, VB, 1982) |
"It is important to treat constipation to avoid recurrent tears in the anal canal." | 2.66 | Anal Fissure in Children. ( Patkova, B; Wester, T, 2020) |
"Anal fissures are common conditions, presenting with bleeding, itching, and pain of varying severity." | 2.41 | Anal fissures. ( Lubowski, DZ, 2000) |
"Pain and constipation were assessed prior to treatment and at 6 weeks after therapy using visual analogue scale (VAS) and Wexner constipation score." | 1.46 | Does the duration of symptoms of anal fissure impact its response to conservative treatment? A prospective cohort study. ( Abdelmawla, AA; Abdelnaby, M; Elfeki, H; Elgendy, H; Emile, SH; Khafagy, W; Magdy, A, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (42.86) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Patkova, B | 1 |
Wester, T | 1 |
Emile, SH | 1 |
Elgendy, H | 1 |
Elfeki, H | 1 |
Magdy, A | 1 |
Abdelmawla, AA | 1 |
Abdelnaby, M | 1 |
Khafagy, W | 1 |
Balasubramanian, V | 1 |
Raftery, EB | 1 |
Weiner, DA | 1 |
Klein, MD | 1 |
Scheidt, S | 1 |
Frishman, WH | 1 |
Packer, M | 1 |
Mehta, J | 1 |
Parodi, O | 1 |
Subramanian, VB | 1 |
Guillemot, F | 1 |
Leroi, H | 1 |
Lone, YC | 1 |
Rousseau, CG | 1 |
Lamblin, MD | 1 |
Cortot, A | 1 |
Lubowski, DZ | 1 |
2 reviews available for nitroglycerin and Constipation
Article | Year |
---|---|
Anal Fissure in Children.
Topics: Botulinum Toxins; Calcium Channel Blockers; Child; Conservative Treatment; Constipation; Fissure in | 2020 |
Anal fissures.
Topics: Chronic Disease; Constipation; Dietary Fiber; Digestive System Surgical Procedures; Fissure in Ano; | 2000 |
3 trials available for nitroglycerin and Constipation
Article | Year |
---|---|
An objective comparison of verapamil and placebo in chronic stable angina.
Topics: Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Constipation; Elec | 1982 |
Verapamil therapy for stable exertional angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Constipation; Double-Blind M | 1982 |
Long-term effectiveness of verapamil in stable and unstable angina pectoris. One-year follow-up of patients treated in placebo-controlled double-blind randomized clinical trials.
Topics: Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Constipation; Doub | 1982 |
2 other studies available for nitroglycerin and Constipation
Article | Year |
---|---|
Does the duration of symptoms of anal fissure impact its response to conservative treatment? A prospective cohort study.
Topics: Acute Disease; Adolescent; Adult; Aged; Chronic Disease; Conservative Treatment; Constipation; Femal | 2017 |
Action of in situ nitroglycerin on upper anal canal pressure of patients with terminal constipation. A pilot study.
Topics: Administration, Rectal; Adult; Anal Canal; Constipation; Female; Humans; Male; Middle Aged; Muscle H | 1993 |